Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells

J Cell Physiol. 2013 Nov;228(11):2202-9. doi: 10.1002/jcp.24385.

Abstract

Vanadium compounds can exert anticancer effects, partly due to inhibition of tyrosine phosphatases. Here, we report the effect of N,N'-ethylenebis (pyridoxylideneiminato) vanadium (IV) complex (Pyr2 enV(IV)), that induced 93% and 57% of cell mortality in A375 (human melanoma) and A549 (human lung carcinoma) cells, respectively; the mortality was <24% in other cancer cell lines and in human normal epidermal keratinocytes, lung cells and peripheral blood mononuclear cells. The mechanism of Pyr2 enV(IV) effect relied on apoptosis induction; this was triggered by ROS increase, followed by mitochondrial membrane depolarization. Indeed, the addition of N-acetyl cysteine to cell cultures abated Pyr2 enV(IV)-induced apoptosis. These results disclose the pro-apoptotic activity of Pyr2 enV(IV) and its mechanism, relying on intracellular ROS increase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Caspases / metabolism
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Inhibitory Concentration 50
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • Membrane Potential, Mitochondrial / drug effects
  • Neoplasms / drug therapy*
  • Neoplasms / pathology*
  • Pyridoxal / chemistry
  • Pyridoxal / pharmacology
  • Pyridoxal / therapeutic use*
  • Reactive Oxygen Species / metabolism
  • Tumor Stem Cell Assay
  • Vanadium / chemistry
  • Vanadium / pharmacology
  • Vanadium / therapeutic use*

Substances

  • Reactive Oxygen Species
  • Vanadium
  • Pyridoxal
  • Caspases
  • Acetylcysteine